Cherqui G, Caron M, Wicek D, Lascols O, Capeau J, Picard J
Endocrinology. 1986 May;118(5):1759-69. doi: 10.1210/endo-118-5-1759.
The hypothesis that insulin stimulation of glucose and lipid metabolism in rat adipocytes may involve the activation of protein kinase C was evaluated. 4 beta-Phorbol 12 beta-myristate, 13 alpha-acetate (PMA, 0.1-1000 ng/ml), a potent tumor promoter acting as a substitute for diacylglycerol to activate protein kinase C, stimulated 2-deoxyglucose transport in a time- and dose-dependent manner, without affecting passive glucose diffusion. PMA (0.1-1000 ng/ml) also elicited a dose-dependent activation of lipogenesis from [3-3H] glucose. Maximal PMA effects (100 ng/ml) on both processes were 60% of insulin maximal effects. In contrast, PMA (1-1000 ng/ml) failed to mimic the ability of insulin to stimulate lipogenesis from [3H]acetate. 4 beta-Phorbol 12,13 dibutyrate, mezerein, 1-oleyl-2-acetyl-glycerol, 1,2 diolein, known as protein kinase C activators, also markedly stimulated glucose metabolism whereas 4 alpha-phorbol 12,13 didecanoate and 4 beta-phorbol 13-monoacetate, shown not to activate protein kinase C, were ineffective. Mellitin, a cytotoxin-inhibiting protein kinase C, markedly decreased both PMA and insulin stimulation of glucose metabolism. PMA decreased insulin submaximal effects on 2-deoxyglucose transport without inhibiting insulin binding. Maximal PMA and insulin effects on 2-deoxyglucose transport and lipogenesis from [3-3H]glucose were not additive. Both PMA and insulin activated each metabolic process in a calcium-dependent manner. PMA, like insulin, no longer stimulated 2-deoxyglucose transport in fat cells treated with 2,4-dinitrophenol. These data show that PMA exhibited specific insulin-like properties on glucose metabolism in fat cells, without any effect on lipid synthesis from acetate. They indicate that PMA and insulin bioeffects may share a common step implicating a calcium- and energy-dependent process, distal to the initial insulin binding event. Our results suggest that protein kinase C may play a role in insulin regulation of glucose metabolism.
对胰岛素刺激大鼠脂肪细胞中葡萄糖和脂质代谢可能涉及蛋白激酶C激活这一假说进行了评估。4β-佛波醇12β-肉豆蔻酸酯13α-乙酸酯(PMA,0.1 - 1000 ng/ml),一种强效肿瘤促进剂,可作为二酰基甘油的替代品来激活蛋白激酶C,它以时间和剂量依赖的方式刺激2-脱氧葡萄糖转运,且不影响葡萄糖的被动扩散。PMA(0.1 - 1000 ng/ml)还引发了[3 - 3H]葡萄糖生成脂肪的剂量依赖性激活。PMA对这两个过程的最大效应(100 ng/ml)为胰岛素最大效应的60%。相比之下,PMA(1 - 1000 ng/ml)无法模拟胰岛素刺激[3H]乙酸酯生成脂肪的能力。4β-佛波醇12,13 - 二丁酸酯、蜂毒素、1-油酰基-2-乙酰甘油、1,2 - 二油精,这些已知的蛋白激酶C激活剂也显著刺激葡萄糖代谢,而4α-佛波醇12,13 - 二癸酸酯和4β-佛波醇13 - 单乙酸酯,已证明它们不激活蛋白激酶C,无此作用。蜂毒肽,一种抑制蛋白激酶C的细胞毒素,显著降低了PMA和胰岛素对葡萄糖代谢的刺激作用。PMA降低了胰岛素对2-脱氧葡萄糖转运的次最大效应,但不抑制胰岛素结合。PMA和胰岛素对2-脱氧葡萄糖转运以及[3 - 3H]葡萄糖生成脂肪的最大效应并非相加的。PMA和胰岛素均以钙依赖的方式激活每个代谢过程。PMA与胰岛素一样,在用2,4 - 二硝基苯酚处理的脂肪细胞中不再刺激2-脱氧葡萄糖转运。这些数据表明,PMA在脂肪细胞的葡萄糖代谢上表现出特定的胰岛素样特性,而对乙酸酯的脂质合成无任何影响。它们表明PMA和胰岛素的生物效应可能共享一个涉及钙和能量依赖过程的共同步骤,该步骤在初始胰岛素结合事件之后。我们的结果表明蛋白激酶C可能在胰岛素对葡萄糖代谢的调节中起作用。